Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5655-00-5

1H-Pyrrolo[3,4-c]pyridin-1-one, 2,3-dihydro- is a heterocyclic compound with the molecular formula C8H8N2O. It features a pyrrolo[3,4-c]pyridine core, which consists of a pyrrole ring fused to a pyridine ring. The compound is a derivative of pyrrolo[3,4-c]pyridin-1-one, with two additional hydrogen atoms attached to the second and third carbon atoms, resulting in a dihydro structure. This chemical is of interest in medicinal chemistry and drug discovery due to its potential biological activities and its ability to form the basis for various pharmaceutical compounds.

5655-00-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 5655-00-5 Structure

  • Basic information

    1. Product Name: 1H-Pyrrolo[3,4-c]pyridin-1-one, 2,3-dihydro-
    2. Synonyms: 1H-Pyrrolo[3,4-c]pyridin-1-one, 2,3-dihydro-;2,3-Dihydro-pyrrolo[3,4-c]pyridin-1-one
    3. CAS NO:5655-00-5
    4. Molecular Formula: C7H6N2O
    5. Molecular Weight: 134.13534
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 5655-00-5.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 441.7±34.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.286±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. PKA: 12.26±0.20(Predicted)
    10. CAS DataBase Reference: 1H-Pyrrolo[3,4-c]pyridin-1-one, 2,3-dihydro-(CAS DataBase Reference)
    11. NIST Chemistry Reference: 1H-Pyrrolo[3,4-c]pyridin-1-one, 2,3-dihydro-(5655-00-5)
    12. EPA Substance Registry System: 1H-Pyrrolo[3,4-c]pyridin-1-one, 2,3-dihydro-(5655-00-5)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 5655-00-5(Hazardous Substances Data)

5655-00-5 Usage

Compound type

Heterocyclic compound

Derivative

Pyrrolopyridine

Natural occurrence

Found in foods such as coffee and tobacco smoke, as well as in various plants and animals

Biological activities

Potential neurotoxin, potential anticancer agent

Industrial use

Building block in organic synthesis, its derivatives have been investigated for pharmaceutical applications.

Check Digit Verification of cas no

The CAS Registry Mumber 5655-00-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,6,5 and 5 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5655-00:
(6*5)+(5*6)+(4*5)+(3*5)+(2*0)+(1*0)=95
95 % 10 = 5
So 5655-00-5 is a valid CAS Registry Number.

5655-00-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3-dihydropyrrolo[3,4-c]pyridin-1-one

1.2 Other means of identification

Product number -
Other names 1H,2H,3H-PYRROLO[3,4-C]PYRIDIN-1-ONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5655-00-5 SDS

5655-00-5Upstream product

5655-00-5Relevant articles and documents

Synthesis and biological activity of conformationally restricted indole-based inhibitors of neurotropic alphavirus replication: Generation of a three-dimensional pharmacophore

Barraza, Scott J.,Sindac, Janice A.,Dobry, Craig J.,Delekta, Philip C.,Lee, Pil H.,Miller, David J.,Larsen, Scott D.

supporting information, (2021/06/18)

We have previously reported the development of indole-based CNS-active antivirals for the treatment of neurotropic alphavirus infection, but further optimization is impeded by a lack of knowledge of the molecular target and binding site. Herein we describe the design, synthesis and evaluation of a series of conformationally restricted analogues with the dual objectives of improving potency/selectivity and identifying the most bioactive conformation. Although this campaign was only modestly successful at improving potency, the sharply defined SAR of the rigid analogs enabled the definition of a three-dimensional pharmacophore, which we believe will be of value in further analog design and virtual screening for alternative antiviral leads.

NOVEL TRIAZINE COMPOUNDS

-

Page/Page column 72, (2012/08/08)

The present invention relates to novel triazine compounds of formula (1), methods of their preparation, pharmaceutical compositions containing these compounds and the use of these compounds to treat proliferative disorders such as tumors and cancers and also other conditions and disorders related to or associated with dysregulation of PI3 Kinases, PI3 Kinase pathway, mTOR and/ or the mTOR pathway.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5655-00-5